• Skip to primary navigation
  • Skip to content
  • Skip to footer navigation
Aucta Pharma

Aucta Pharma

  • About Aucta
    • Aucta Introduction
    • Aucta Values
    • Aucta Vision
    • Management Team
  • Strategy
    • Strategy
    • R&D
    • Commercial
    • Manufacturing
  • Product Portfolio
    • Pipeline
    • Branded Products
    • Generic Products
    • Partnered Products
    • Partnering
  • Therapeutic Area
    • Therapeutic Area
    • Central Nervous System
    • Orphan and Specialty
  • Investors
    • Investors
    • Press Release/News
  • Working at Aucta
    • Careers
    • Employee Value Propostion
  • Contact Us
  • English
    • 简体中文
  • Aucta Introduction
  • Aucta Values
  • Aucta Vision
  • Management Team
Shoufeng Li, Ph.D.
21副本.pngChief Executive Officer

Dr. Li is a Scientist and Founder of the company. With 20+ years of global pharmaceutical industry experience in both multinational and start-ups, he is responsible for the overall strategy, direction, and growth of the business. 

Before founding Aucta, Dr. Li held scientific and managerial roles at Novartis Pharmaceuticals and Eon Labs (Sandoz).

Dr. Li holds a PhD in Pharmaceutics and an MS in Statistics from Rutgers University.

Brian Zorn, Pharm.D.
22副本.pngExecutive Director

Pharm.D. in Pharmacy from University of Kansas

Dr. Zorn with 30+ years of pharmaceutical industry experience, including product management, global product planning, business development, medical communications, KOL (Key Opinion Leader) engagement and sales.

Qiaolin Ren, Ph.D.

1768898006387082uI3r.jpg

Vice President

Ph.D. in Pharmaceutics from St. John's University

With 20+ years of pharmaceutical expertise across leading companies including Fougera, Sandoz, Novartis.

Lisheng Lu

1768898931482187VwYD.pngExecutie Director and Vice President of Manufacture (CN)

B.S. in Pharmaceutics from Shenyang Pharmaceutical University.

He served as director and head position of production & operations at Shandong Jingwei Pharmaceutical Co., Ltd, Taifeng Pharmaceutical Technology Group and Shandong Lusheng Pharmaceutical Co., Ltd. overseeing multiple facility constructions and product commercialization, with 20 years of experience in China’s production.

Rong Li Ph.D.

默认文件1768898822135.pngScientic Advisor

B.S. from Tsinghua University, Beijing, and a Ph.D. in Medicinal Chemistry from the University of Kansas.

20+ years of expertise in pharmacokinetics, formulation development, drug absorption, PBPK, and IVIVC modeling.

Previously with Pfizer and other leading global pharmaceutical companies, having successfully advanced over ten products to market.


Chris Jarman
25副本.pngVice President, Managed Markets and Operations

25+ years of pharmaceutical expertise, with senior leadership roles at Optum, Almirall, and Purdue prior to Aucta.

Changjun Liu

默认文件1768898776810.pngVP, Quality Management

B.S. in Pharmaceutics from Shenyang Pharmaceutical University.

Over 25 years of experience in the pharmaceutical industry, including 20 years in international pharmaceutical companies. Licensed Pharmacist with extensive expertise in Quality Management and GMP compliance. Previously held senior leadership positions at Janssen, Ipsen, and YilingPharmaceutical.


Lixin Gong
26副本.pngHead of Analysis

With 20 years of pharmaceutical industry experience, Ms. Gong is responsible for analytical development and quality management. She has in-depth knowledge and experience of analytical method development and validation and a solid understanding of quality systems and GMP/GLP/FDA/ICH and DEA regulations.                     

Prior to joining Aucta, she held roles of increasing responsibility with West-Ward, Alpharma, and Bristol-Myers Squibb.Ms. Gong holds a BS in Organic Chemistry and an MS in Analytical Chemistry from Northeastern University, Shenyang,China.

  • About Aucta
  • Strategy
  • Product Portfolio
  • Therapeutic Area
  • Investors
  • Contact Us
  • English
Address:71 Suttons Lane, Piscataway, New Jersey 08854 • Phone: +1 (732) 640-0030 • Privacy Policy •  • CA Disclosure